Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa 2019-05-10 09:24
OliX Pharmaceuticals Announces The Ophthalmologist Demetrios G. Vavvas, M.D., Ph.D., to join Scientific Advisory Board 2019-04-22 13:32
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy 2019-01-18 14:50
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing 2018-07-23 14:42
1